BDBM50564217 CHEMBL4783427

SMILES CCN(CCCCOc1ccc(cc1)-c1cc(=O)c2c(O)cc(OCCCCN(CC)Cc3ccccc3)cc2o1)Cc1ccccc1

InChI Key InChIKey=ZLKRKOVDOXDQDL-UHFFFAOYSA-N

Data  1 KI  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 50564217   

TargetAcetylcholinesterase(Electric eel)
Nanyang Normal University

Curated by ChEMBL
LigandPNGBDBM50564217(CHEMBL4783427)
Affinity DataIC50: 3.70E+3nMAssay Description:Inhibition of electric eel AChE by Ellman's methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetCholinesterase(Horse)
Nanyang Normal University

Curated by ChEMBL
LigandPNGBDBM50564217(CHEMBL4783427)
Affinity DataIC50: 9.60E+3nMAssay Description:Inhibition of equine serum BChE by Ellman's methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Nanyang Normal University

Curated by ChEMBL
LigandPNGBDBM50564217(CHEMBL4783427)
Affinity DataIC50: 360nMAssay Description:Inhibition of AChE in human erythrocytes by Ellman's methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetCholinesterase(Human)
Nanyang Normal University

Curated by ChEMBL
LigandPNGBDBM50564217(CHEMBL4783427)
Affinity DataIC50: 1.53E+4nMAssay Description:Inhibition of human serum BChE by Ellman's methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Nanyang Normal University

Curated by ChEMBL
LigandPNGBDBM50564217(CHEMBL4783427)
Affinity DataKi:  394nMAssay Description:Mixed type inhibition of human AChE using acetylthiocholine as substrate by Line-weaver Burk plot analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed